Beyond MASLD, emerging preclinical evidence highlights the therapeutic potential of GLP-1 RAs in ALD and MetALD (Singal and Leggio, 2025)
Since the stomach empties more slowly on GLP-1 meds, patients who continue to eat two or three times a day often overload their gutand get the predictable nausea, bloating, and constipation that can come with that
Neurochem 128 , 459471 (2014)
In this article, well explore each of these next-gen GLP-1 medicines in plain language: how they work, what the studies show, when they might be available, and what patients should know about pairing them with lifestyle choices for the best results
GLP-1 medications slow down gastric emptying, leading to fermentation of food in the stomach and the production of hydrogen sulfide gas, which can result in sulfur burps
Here at the WVU Medicine Advanced Center for Endoscopy , we are now seeing patients maintaining their weight loss one year after discontinuing GLP-1 medications